Achilles Therapeutics Regains Nasdaq Compliance, Boosting Investor Confidence

Date:

December 2, 2024

Achilles Therapeutics (ACHL) has released an update.

Don’t Miss our Black Friday Offers:

Achilles Therapeutics has successfully regained compliance with Nasdaq’s minimum bid price requirement, ensuring its continued listing on the Nasdaq Capital Market. After a challenging period where its shares fell below the $1.00 threshold, the company has managed to stabilize its stock price above this crucial level. This development marks a positive turnaround for the company, reassuring investors of its market standing.

For further insights into ACHL stock, check out TipRanks’ Stock Analysis page.

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Achilles Therapeutics Regains Nasdaq Compliance, Boosting Investor Confidence

Don’t Miss our Black Friday Offers:

Subscribe

Tampa RV giant Lazydays to delist from Nasdaq

Granite Geek: New Hampshire might get access to ‘balcony solar’

TSX Today: What to Watch for in Stocks on Monday, November 10

While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!

Barrick hikes dividend, extends buyback after profit beat on record gold prices

More like this
Related

Tampa RV giant Lazydays to delist from Nasdaq

Granite Geek: New Hampshire might get access to ‘balcony solar’

TSX Today: What to Watch for in Stocks on Monday, November 10

While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!

About us

Company

The latest

Tampa RV giant Lazydays to delist from Nasdaq

Granite Geek: New Hampshire might get access to ‘balcony solar’

TSX Today: What to Watch for in Stocks on Monday, November 10

Subscribe

Achilles Therapeutics Regains Nasdaq Compliance, Boosting Investor Confidence

Don’t Miss our Black Friday Offers:

Subscribe

More like thisRelated

About us

Company

The latest

Subscribe

More like this
Related